Wireless, internet-based medical-diagnostic system
First Claim
1. A system for monitoring a patient, comprising:
- a vital-sign monitor comprising sensors for measuring from the patient at least one of the following vital-sign data;
O2 saturation, blood pressure, heart rate, electro-cardiogram, respiratory rate, temperature and blood glucose level;
a global positioning system for determining location-based data;
a wireless transmitter configured to receive the vital-sign and location-based data and wirelessly transmit these data through a wireless network;
a gateway software piece that receives and processes the vital-sign and location-based data from the wireless network;
a database software piece that communicates with the gateway software piece to receive the vital-sign and location-based data and stores them in a computer memory; and
an Internet-based user interface that displays the vital sign and location-based data.
2 Assignments
0 Petitions

Accused Products

Abstract
A system for monitoring a patient'"'"'s vital signs that features a vital-sign monitor including sensors for measuring from the patient at least one of the following vital-sign data: O2 saturation, blood pressure, electro-cardiogram, respirator rate, and blood glucose level. The system also includes a global positioning system that determines location-based data. A wireless transmitter, in electrical contact with the vital-sign monitor and global positioning system, receives the vital-sign and location-based data and wirelessly transmits these data through a conventional wireless network. A gateway software piece receives and processes the data from the wireless network and stores these data in a computer memory associated with a database software piece. The system also includes an Internet-based user interface that displays the vital sign data for both individual patients and care-providers.
354 Citations
Analyte monitoring device and methods of use | ||
Patent #
US 7,885,699 B2
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Prescription Zero: A non-pharmaceutical prescription device for prescribing, administering, monitoring, measuring and motivating a therapeutic lifestyle regimen for prevention and treatment of chronic diseases | ||
Patent #
US 20110046519A1
Filed 08/21/2009
|
Current Assignee
Fazal Raheman
|
Original Assignee
Fazal Raheman
|
Method and Apparatus for Providing Notification Function in Analyte Monitoring Systems | ||
Patent #
US 20110077494A1
Filed 09/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose Measuring Device for Use In Personal Area Network | ||
Patent #
US 20110046469A1
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,869,853 B1
Filed 08/06/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for secure voice identification in a medical device | ||
Patent #
US 7,925,511 B2
Filed 09/29/2006
|
Current Assignee
Covidien LP
|
Original Assignee
Nellcor Puritan Bennett LLC
|
Intelligent User Interface For Medical Monitors | ||
Patent #
US 20110118557A1
Filed 11/18/2010
|
Current Assignee
Covidien LP
|
Original Assignee
Nellcor Puritan Bennett LLC
|
Analyte monitoring system and method | ||
Patent #
US 7,920,907 B2
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
DIABETES HEALTH MANAGEMENT SYSTEMS AND METHODS | ||
Patent #
US 20110124996A1
Filed 11/20/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diagnostics Operations Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 7,928,850 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Self-Similar Medical Communications System | ||
Patent #
US 20110225008A1
Filed 03/09/2010
|
Current Assignee
RESPIRA DV LLC
|
Original Assignee
RESPIRA DV LLC
|
Blood glucose tracking apparatus | ||
Patent #
US 7,976,778 B2
Filed 06/22/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
COMMUNICATING IN-CASINO EMERGENCY NOTIFICATIONS | ||
Patent #
US 20110205068A1
Filed 11/12/2009
|
Current Assignee
Sg Gaming Inc.
|
Original Assignee
WMS Gaming Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,066,639 B2
Filed 06/04/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Error Detection in Critical Repeating Data in a Wireless Sensor System | ||
Patent #
US 20100275108A1
Filed 04/28/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 7,860,544 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Optimizing Analyte Sensor Calibration | ||
Patent #
US 20100081909A1
Filed 09/30/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and Device for Providing Offset Model Based Calibration for Analyte Sensor | ||
Patent #
US 20100191085A1
Filed 01/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System And Method For Displaying Detailed Information For A Data Point | ||
Patent #
US 20100081891A1
Filed 09/30/2008
|
Current Assignee
Nellcor Puritan Bennett LLC
|
Original Assignee
Nellcor Puritan Bennett LLC
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 7,811,231 B2
Filed 12/26/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and System for Powering an Electronic Device | ||
Patent #
US 20100045231A1
Filed 11/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and Method for Interfacing Cellular Matter with a Machine | ||
Patent #
US 20100022908A1
Filed 09/14/2009
|
Current Assignee
Board of Regents of the University of Texas System
|
Original Assignee
Board of Regents of the University of Texas System
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 7,766,829 B2
Filed 11/04/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA | ||
Patent #
US 20100331657A1
Filed 09/10/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Apolipoprotein E genotyping and accompanying internet-based health management system | ||
Patent #
US 7,842,506 B2
Filed 02/06/2007
|
Current Assignee
Berkeley HeartLab Inc.
|
Original Assignee
Berkeley HeartLab Inc.
|
Alarm Characterization for Analyte Monitoring Devices and Systems | ||
Patent #
US 20100121167A1
Filed 11/10/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA | ||
Patent #
US 20100331656A1
Filed 09/10/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and Method for Monitoring Athletic Performance | ||
Patent #
US 20100185398A1
Filed 01/22/2010
|
Current Assignee
Under Armour Incorporated
|
Original Assignee
Under Armour Incorporated
|
Method And Device For Determining Elapsed Sensor Life | ||
Patent #
US 20100014626A1
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for analysis of medical data | ||
Patent #
US 7,788,343 B2
Filed 10/02/2006
|
Current Assignee
PHD Medical Inc.
|
Original Assignee
PHD Medical Inc.
|
Single use pulse oximeter | ||
Patent #
US 7,486,977 B2
Filed 10/27/2005
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical MD Incorporated
|
Method and System for Providing Data Transmission in a Data Management System | ||
Patent #
US 20090054749A1
Filed 05/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte sensor tester isolation | ||
Patent #
US 20090054747A1
Filed 10/31/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and Method for Detecting Viewer Attention to Media Delivery Devices | ||
Patent #
US 20090070798A1
Filed 09/08/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Method and Apparatus for Sensing Blood Oxygen | ||
Patent #
US 20090069652A1
Filed 09/07/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Method and System for Providing Analyte Monitoring | ||
Patent #
US 20090069649A1
Filed 09/26/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Single use pulse oximeter | ||
Patent #
US 7,499,739 B2
Filed 10/27/2005
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical MD Incorporated
|
Method and System for Providing Data Communication in Data Management Systems | ||
Patent #
US 20090105571A1
Filed 06/30/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System for Remote Access to Media, and Reaction and Survey Data From Viewers of the Media | ||
Patent #
US 20090094286A1
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Providing Actionable Insights Based on Physiological Responses From Viewers of Media | ||
Patent #
US 20090094629A1
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
System Providing Actionable Insights Based on Physiological Responses From Viewers of Media | ||
Patent #
US 20090094628A1
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Providing Remote Access to Media, and Reaction and Survey Data From Viewers of the Media | ||
Patent #
US 20090094627A1
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Single use pulse oximeter | ||
Patent #
US 20090131774A1
Filed 01/23/2009
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical MD Incorporated
|
Systems and Methods Providing Distributed Collection and Centralized Processing of Physiological Responses from Viewers | ||
Patent #
US 20090133047A1
Filed 10/31/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
ANALYTE SENSOR | ||
Patent #
US 20090131777A1
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090137887A1
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090137886A1
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Correlating Media Instance Information With Physiological Responses From Participating Subjects | ||
Patent #
US 20090150919A1
Filed 12/01/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Medical Monitoring With Portable Electronic Device System And Method | ||
Patent #
US 20090171170A1
Filed 12/24/2008
|
Current Assignee
Nellcor Puritan Bennett LLC
|
Original Assignee
Nellcor Puritan Bennett LLC
|
ANALYTE SENSOR | ||
Patent #
US 20090178459A1
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Personalized Medical Monitoring: Auto-Configuration Using Patient Record Information | ||
Patent #
US 20090171175A1
Filed 12/24/2008
|
Current Assignee
Covidien LP
|
Original Assignee
Nellcor Puritan Bennett LLC
|
METHOD AND APPARATUS TO DETERMINE SKIN STEROL LEVELS | ||
Patent #
US 20090216096A1
Filed 12/29/2008
|
Current Assignee
Nellcor Puritan Bennett LLC
|
Original Assignee
Nellcor Puritan Bennett LLC
|
EXTERNAL USER INTERFACE BASED MEASUREMENT ASSOCIATION | ||
Patent #
US 20090205042A1
Filed 12/08/2006
|
Current Assignee
Koninklijke Philips N.V.
|
Original Assignee
Koninklijke Philips N.V.
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216101A1
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and process for distant pulse diagnosis | ||
Patent #
US 20090204668A1
Filed 02/12/2009
|
Current Assignee
Sydney Furan Huang
|
Original Assignee
Sydney Furan Huang
|
Household health monitoring system | ||
Patent #
US 20090216090A1
Filed 02/26/2008
|
Current Assignee
SINBON Electronics Co. Ltd.
|
Original Assignee
SINBON Electronics Co. Ltd.
|
SYSTEMS AND METHODS FOR CUSTOMIZING DELIVERY OF SENSOR DATA | ||
Patent #
US 20090240193A1
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA | ||
Patent #
US 20090240120A1
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Implantable Biosensor Assembly and Health Monitoring system and Method including same | ||
Patent #
US 20090221882A1
Filed 12/10/2006
|
Current Assignee
CardioArt Technologies Ltd.
|
Original Assignee
CardioArt Technologies Ltd.
|
Integrated Sensor Headset | ||
Patent #
US 20090253996A1
Filed 09/08/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
System and Method for Communicating Environmentally-Based Medical Advice | ||
Patent #
US 20090265186A1
Filed 11/10/2006
|
Current Assignee
E-San Limited
|
Original Assignee
E-San Limited
|
Method and system for powering an electronic device | ||
Patent #
US 7,620,438 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and System for Providing Analyte Monitoring | ||
Patent #
US 20090281407A1
Filed 07/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 7,630,748 B2
Filed 10/25/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Patient Monitor Alarm System And Method | ||
Patent #
US 20090326340A1
Filed 06/30/2008
|
Current Assignee
Covidien LP
|
Original Assignee
Covidien LP
|
Analyte Monitoring System and Methods | ||
Patent #
US 20090318792A1
Filed 08/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring System and Methods | ||
Patent #
US 20090318789A1
Filed 08/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING SYSTEM AND METHOD | ||
Patent #
US 20080064937A1
Filed 06/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device And Methods Of Use | ||
Patent #
US 20080091094A1
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and method for secure voice identification in a medical device | ||
Patent #
US 20080082339A1
Filed 09/29/2006
|
Current Assignee
Covidien LP
|
Original Assignee
Nellcor Puritan Bennett Incorporated
|
Method and system for analysis of medical data | ||
Patent #
US 20080082659A1
Filed 10/02/2006
|
Current Assignee
PHD Medical Inc.
|
Original Assignee
PHD Medical Inc.
|
Intelligent personal health management appliances for the measurement and monitoring of health factors and controlled delivery of drugs | ||
Patent #
US 20080139907A1
Filed 12/19/2004
|
Current Assignee
IP Holdings Incorporated
|
Original Assignee
IP Holdings Incorporated
|
METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR REAL-TIME DETECTION OF SENSITIVITY DECLINE IN ANALYTE SENSORS | ||
Patent #
US 20080172205A1
Filed 10/26/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20080200791A1
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHOD AND SYSTEM FOR MEASURING AND RANKING AN "ENGAGEMENT" RESPONSE TO AUDIOVISUAL OR INTERACTIVE MEDIA, PRODUCTS, OR ACTIVITIES USING PHYSIOLOGICAL SIGNALS | ||
Patent #
US 20080221400A1
Filed 08/28/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Apparatus and Method for Objectively Determining Human Response to Media | ||
Patent #
US 20080214902A1
Filed 03/02/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Josh Wilson, Michael Fettiplace, Hans C. Lee, Michael J Lee
|
Method And System For Measuring And Ranking A "Thought" Response To Audiovisual Or Interactive Media, Products Or Activities Using Physiological Signals | ||
Patent #
US 20080221969A1
Filed 08/08/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Emsense Corporation
|
METHOD AND APPARATUS FOR PROVIDING ROLLING DATA IN COMMUNICATION SYSTEMS | ||
Patent #
US 20080214900A1
Filed 03/01/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
METHOD AND SYSTEM FOR MEASURING AND RANKING A POSITIVE OR NEGATIVE RESPONSE TO AUDIOVISUAL OR INTERACTIVE MEDIA, PRODUCTS OR ACTIVITIES USING PHYSIOLOGICAL SIGNALS | ||
Patent #
US 20080221472A1
Filed 08/28/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Method and system for rating media and events in media based on physiological data | ||
Patent #
US 20080222671A1
Filed 05/17/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Method and system for using coherence of biological responses as a measure of performance of a media | ||
Patent #
US 20080222670A1
Filed 05/17/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Electronic support system for biological data sensor | ||
Patent #
US 20080281298A1
Filed 02/07/2006
|
Current Assignee
University of Iowa Research Foundation
|
Original Assignee
University of Iowa Research Foundation
|
ANALYTE MONITORING SYSTEM AND METHODS | ||
Patent #
US 20080278333A1
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING SYSTEM AND METHODS | ||
Patent #
US 20080281840A1
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for disease control and management | ||
Patent #
US 20080306770A1
Filed 02/21/2008
|
Current Assignee
Welldoc Communications Inc.
|
Original Assignee
WellDoc Inc
|
Reagentless optical analyte detection system | ||
Patent #
US 20070066877A1
Filed 04/04/2006
|
Current Assignee
University of Iowa Research Foundation
|
Original Assignee
University of Iowa Research Foundation
|
Device and method for sensing electrical activity in tissue | ||
Patent #
US 20070055169A1
Filed 08/08/2006
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Single use pulse oximeter | ||
Patent #
US 20070100219A1
Filed 10/27/2005
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical MD Incorporated
|
Single use pulse oximeter | ||
Patent #
US 20070100218A1
Filed 10/27/2005
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical MD Incorporated
|
NON-ENCUMBERING, SUBSTANTIALLY CONTINUOUS PATIENT DAILY ACTIVITY DATA MEASUREMENT FOR INDICATION OF PATIENT CONDITION CHANGE FOR ACCESS BY REMOTE CAREGIVER | ||
Patent #
US 20070123754A1
Filed 11/29/2005
|
Current Assignee
General Electric Company
|
Original Assignee
General Electric Company
|
DEVICES AND METHODS FOR SELF-ADMINISTERED ECG EXAMINATIONS | ||
Patent #
US 20070149888A1
Filed 12/14/2006
|
Current Assignee
General Electric Company
|
Original Assignee
General Electric Company
|
Apolipoprotein E genotyping and accompanying internet-based health management system | ||
Patent #
US 20070224619A1
Filed 02/06/2007
|
Current Assignee
Berkeley HeartLab Inc.
|
Original Assignee
Berkeley HeartLab Inc.
|
Quantitative EEG as an identifier of learning modality | ||
Patent #
US 20060257834A1
Filed 05/09/2006
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Method and apparatus for providing leak detection in data monitoring and management systems | ||
Patent #
US 20060247508A1
Filed 04/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Wireless sensor system | ||
Patent #
US 20060247505A1
Filed 04/27/2006
|
Current Assignee
SENSOR MOBILITY LLC
|
Original Assignee
SENSOR MOBILITY LLC
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 20040186365A1
Filed 12/26/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Therasense Incorporated
|
Remote speaker microphone having vital sign monitoring capability | ||
Patent #
US 20040243005A1
Filed 05/29/2003
|
Current Assignee
Motorola Inc.
|
Original Assignee
Motorola Inc.
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 8,123,686 B2
Filed 03/01/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
BLOOD GLUCOSE MONITOR WITH AN INTEGRATED DATA MANAGEMENT SYSTEM | ||
Patent #
US 20070282186A1
Filed 05/02/2007
|
Current Assignee
Terumo Medical Corporation
|
Original Assignee
Terumo Medical Corporation
|
System and methods for chronic disease management and health assessment | ||
Patent #
US 20070288266A1
Filed 05/31/2007
|
Current Assignee
Welldoc Communications Inc.
|
Original Assignee
Yves Nordmann, Suzanne Sysko, Shimon Zilbershlag
|
SYSTEM AND METHOD FOR REMOTE MEDICAL DEVICE OPERATION | ||
Patent #
US 20070299316A1
Filed 06/21/2006
|
Current Assignee
PHD Medical Inc.
|
Original Assignee
PHD Medical Inc.
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,103,456 B2
Filed 01/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing leak detection in data monitoring and management systems | ||
Patent #
US 8,112,240 B2
Filed 04/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors | ||
Patent #
US 8,135,548 B2
Filed 10/26/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated, University of Virginia Patent Foundation
|
Analyte monitoring system and methods | ||
Patent #
US 8,149,117 B2
Filed 08/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System for remote access to media, and reaction and survey data from viewers of the media | ||
Patent #
US 8,151,292 B2
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Emsense Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for detecting false hypoglycemic conditions | ||
Patent #
US 8,185,181 B2
Filed 10/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 8,187,183 B2
Filed 10/11/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 8,211,016 B2
Filed 09/26/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration | ||
Patent #
US 8,216,138 B1
Filed 10/23/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 8,216,137 B2
Filed 07/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Optimizing analyte sensor calibration | ||
Patent #
US 8,219,173 B2
Filed 09/30/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for providing offset model based calibration for analyte sensor | ||
Patent #
US 8,224,415 B2
Filed 01/29/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,226,891 B2
Filed 03/31/2006
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for using coherence of biological responses as a measure of performance of a media | ||
Patent #
US 8,230,457 B2
Filed 05/17/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,236,242 B2
Filed 02/12/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 8,268,243 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Prescription zero: a non-pharmaceutical prescription device for prescribing, administering, monitoring, measuring and motivating a therapeutic lifestyle regimen for prevention and treatment of chronic diseases | ||
Patent #
US 8,303,500 B2
Filed 08/21/2009
|
Current Assignee
Fazal Raheman
|
Original Assignee
Fazal Raheman
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System providing actionable insights based on physiological responses from viewers of media | ||
Patent #
US 8,327,395 B2
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Providing actionable insights based on physiological responses from viewers of media | ||
Patent #
US 8,332,883 B2
Filed 10/02/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Identifying key media events and modeling causal relationships between key events and reported feelings | ||
Patent #
US 8,347,326 B2
Filed 12/18/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
Nielsen Company US LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Reagentless optical analyte detection system | ||
Patent #
US 8,204,565 B2
Filed 04/04/2006
|
Current Assignee
University of Iowa Research Foundation
|
Original Assignee
University of Iowa Research Foundation
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,362,904 B2
Filed 04/18/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,364,230 B2
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for sensing blood oxygen | ||
Patent #
US 8,376,952 B2
Filed 09/07/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,425,416 B2
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,447,376 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,449,464 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,456,301 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Single use pulse oximeter | ||
Patent #
US 8,457,704 B2
Filed 01/23/2009
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte monitoring system and methods | ||
Patent #
US 8,461,985 B2
Filed 05/08/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,473,220 B2
Filed 01/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for measuring and ranking a positive or negative response to audiovisual or interactive media, products or activities using physiological signals | ||
Patent #
US 8,473,044 B2
Filed 08/28/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,478,377 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,512,239 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for providing offset model based calibration for analyte sensor | ||
Patent #
US 8,532,935 B2
Filed 07/16/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor calibration management | ||
Patent #
US 8,583,205 B2
Filed 04/16/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 8,585,591 B2
Filed 07/10/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for customizing delivery of sensor data | ||
Patent #
US 8,591,455 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 8,593,287 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 8,593,109 B2
Filed 11/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Devices and methods for self-administered ECG examinations | ||
Patent #
US 8,594,771 B2
Filed 12/14/2006
|
Current Assignee
General Electric Company
|
Original Assignee
General Electric Company
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 8,597,575 B2
Filed 07/23/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Location enabled food database | ||
Patent #
US 8,601,005 B2
Filed 05/27/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
Roche Diagnostics Operations Incorporated
|
Diabetes Monitoring Using Smart Device | ||
Patent #
US 20130332196A1
Filed 06/06/2013
|
Current Assignee
US Department of The Army
|
Original Assignee
US Department of The Army
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 8,622,903 B2
Filed 05/25/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Communicating in-casino emergency notifications | ||
Patent #
US 8,622,823 B2
Filed 11/12/2009
|
Current Assignee
Sg Gaming Inc.
|
Original Assignee
WMS Gaming Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,626,257 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method and system for evaluating analyte sensor response characteristics | ||
Patent #
US 8,635,046 B2
Filed 06/22/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 8,647,269 B2
Filed 04/20/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 8,665,091 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 8,676,513 B2
Filed 06/21/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Intelligent drug delivery appliance | ||
Patent #
US 8,715,177 B2
Filed 02/20/2007
|
Current Assignee
IP Holdings Incorporated
|
Original Assignee
IP Holdings Incorporated
|
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors | ||
Patent #
US 8,718,958 B2
Filed 03/12/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated, University of Virginia Patent Foundation
|
Method and system for providing contextual based medication dosage determination | ||
Patent #
US 8,732,188 B2
Filed 02/15/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Electronic skin patch for real time monitoring of cardiac activity and personal health management | ||
Patent #
US 8,734,339 B2
Filed 11/30/2004
|
Current Assignee
IP Holdings Incorporated
|
Original Assignee
IP Holdings Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Optimizing analyte sensor calibration | ||
Patent #
US 8,744,547 B2
Filed 07/09/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for measuring and ranking an “engagement” response to audiovisual or interactive media, products, or activities using physiological signals | ||
Patent #
US 8,764,652 B2
Filed 08/28/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielson Company US LLC.
|
Blood glucose tracking apparatus | ||
Patent #
US 8,765,059 B2
Filed 10/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 8,771,183 B2
Filed 02/16/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for rating media and events in media based on physiological data | ||
Patent #
US 8,782,681 B2
Filed 05/17/2007
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Identifying key media events and modeling causal relationships between key events and reported feelings | ||
Patent #
US 8,793,715 B1
Filed 11/20/2012
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Apparatus for acquiring, processing and transmitting physiological sounds | ||
Patent #
US 8,870,791 B2
Filed 03/26/2012
|
Current Assignee
Audio Evolution Diagnostics Inc.
|
Original Assignee
Michael E. Sabatino
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Single use pulse oximeter | ||
Patent #
US 8,903,467 B2
Filed 09/13/2012
|
Current Assignee
Smiths Medical ASD Inc.
|
Original Assignee
Smiths Medical ASD Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Apparatus for acquiring and processing of physiological auditory signals | ||
Patent #
US 8,920,343 B2
Filed 11/20/2006
|
Current Assignee
Audio Evolution Diagnostics Inc.
|
Original Assignee
Michael Edward Sabatino
|
Multi-function analyte test device and methods therefor | ||
Patent #
US 8,930,203 B2
Filed 02/03/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 8,933,664 B2
Filed 11/25/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for using coherence of biological responses as a measure of performance of a media | ||
Patent #
US 8,973,022 B2
Filed 07/19/2012
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods to gather and analyze electroencephalographic data | ||
Patent #
US 8,989,835 B2
Filed 12/27/2012
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 8,993,331 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,000,929 B2
Filed 11/22/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System to assess amputee patient function | ||
Patent #
US 8,998,829 B1
Filed 09/20/2010
|
Current Assignee
Modus Health LLC
|
Original Assignee
Orthocare Innovations LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing, transmitting and displaying sensor data | ||
Patent #
US 9,020,572 B2
Filed 09/10/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods to determine media effectiveness | ||
Patent #
US 9,021,515 B2
Filed 10/24/2012
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring system and methods | ||
Patent #
US 9,035,767 B2
Filed 05/30/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,039,975 B2
Filed 12/02/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for detecting false hypoglycemic conditions | ||
Patent #
US 9,050,041 B2
Filed 05/21/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods to gather and analyze electroencephalographic data | ||
Patent #
US 9,060,671 B2
Filed 12/27/2012
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for early signal attenuation detection using blood glucose measurements | ||
Patent #
US 9,066,709 B2
Filed 03/17/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,095,290 B2
Filed 02/27/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 9,113,828 B2
Filed 07/09/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing, transmitting and displaying sensor data | ||
Patent #
US 9,143,569 B2
Filed 02/20/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,177,456 B2
Filed 06/10/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Acute Care Display System | ||
Patent #
US 20150350749A1
Filed 05/30/2014
|
Current Assignee
David Andrew Pybus
|
Original Assignee
David Andrew Pybus
|
Systems and methods to gather and analyze electroencephalographic data | ||
Patent #
US 9,215,978 B2
Filed 01/30/2015
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Apparatus and method for objectively determining human response to media | ||
Patent #
US 9,215,996 B2
Filed 03/02/2007
|
Current Assignee
Josh Wilson, The Nielsen Company LLC, Michael Fettiplace, Hans C. Lee, Michael J Lee
|
Original Assignee
The Nielsen Company LLC
|
Error detection in critical repeating data in a wireless sensor system | ||
Patent #
US 9,226,701 B2
Filed 04/28/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,314,198 B2
Filed 04/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,314,195 B2
Filed 08/31/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 9,320,461 B2
Filed 09/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,323,898 B2
Filed 11/15/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus to gather and analyze electroencephalographic data | ||
Patent #
US 9,320,450 B2
Filed 03/14/2013
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Systems, devices and methods for managing glucose levels | ||
Patent #
US 9,326,709 B2
Filed 03/09/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Alarm characterization for analyte monitoring devices and systems | ||
Patent #
US 9,326,707 B2
Filed 11/10/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for sensing electrical activity in tissue | ||
Patent #
US 9,351,658 B2
Filed 08/08/2006
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Method and system for powering an electronic device | ||
Patent #
US 9,380,971 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System to assess activity level of a user | ||
Patent #
US 9,408,560 B2
Filed 03/16/2015
|
Current Assignee
Modus Health LLC
|
Original Assignee
Modus Health LLC
|
Multi-rate analyte sensor data collection with sample rate configurable signal processing | ||
Patent #
US 9,474,475 B1
Filed 03/13/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Blood glucose tracking apparatus and methods | ||
Patent #
US 9,477,811 B2
Filed 06/23/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods providing en mass collection and centralized processing of physiological responses from viewers | ||
Patent #
US 9,521,960 B2
Filed 10/31/2008
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Systems and methods to determine media effectiveness | ||
Patent #
US 9,571,877 B2
Filed 03/30/2015
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,574,914 B2
Filed 03/03/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Model based variable risk false glucose threshold alarm prevention mechanism | ||
Patent #
US 9,622,691 B2
Filed 10/30/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus to gather and analyze electroencephalographic data | ||
Patent #
US 9,622,703 B2
Filed 09/21/2015
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Methods and apparatus to gather and analyze electroencephalographic data | ||
Patent #
US 9,622,702 B2
Filed 06/02/2014
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Analyte monitoring devices and methods therefor | ||
Patent #
US 9,625,413 B2
Filed 05/19/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 9,649,057 B2
Filed 05/11/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Optimizing analyte sensor calibration | ||
Patent #
US 9,662,056 B2
Filed 05/22/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatus to gather and analyze electroencephalographic data | ||
Patent #
US 9,668,694 B2
Filed 03/23/2016
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Method and system for providing basal profile modification in analyte monitoring and management systems | ||
Patent #
US 9,669,162 B2
Filed 03/16/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensitivity calibration of in vivo sensors used to measure analyte concentration | ||
Patent #
US 9,675,290 B2
Filed 10/29/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose measuring device for use in personal area network | ||
Patent #
US 9,730,584 B2
Filed 02/10/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Alarm characterization for analyte monitoring devices and systems | ||
Patent #
US 9,730,650 B2
Filed 01/15/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for powering an electronic device | ||
Patent #
US 9,743,863 B2
Filed 06/01/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 9,750,439 B2
Filed 04/08/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for disease control and management | ||
Patent #
US 9,754,077 B2
Filed 02/21/2008
|
Current Assignee
Welldoc Communications Inc.
|
Original Assignee
WellDoc Inc
|
Body worn mobile medical patient monitor | ||
Patent #
US 9,788,735 B2
Filed 04/27/2017
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Wearable portable patient monitor | ||
Patent #
US 9,795,300 B2
Filed 04/27/2017
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Method and apparatus for providing rolling data in communication systems | ||
Patent #
US 9,801,545 B2
Filed 07/30/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensitivity calibration of in vivo sensors used to measure analyte concentration | ||
Patent #
US 9,801,577 B2
Filed 06/07/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 9,814,428 B2
Filed 08/22/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Arm mountable portable patient monitor | ||
Patent #
US 9,872,623 B2
Filed 04/24/2017
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors | ||
Patent #
US 9,882,660 B2
Filed 04/30/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated, University of Virginia Patent Foundation
|
Systems and methods to determine media effectiveness | ||
Patent #
US 9,894,399 B2
Filed 01/06/2017
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Systems and methods to gather and analyze electroencephalographic data | ||
Patent #
US 9,907,482 B2
Filed 06/22/2015
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data | ||
Patent #
US 9,907,492 B2
Filed 09/18/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Model based variable risk false glucose threshold alarm prevention mechanism | ||
Patent #
US 9,913,619 B2
Filed 04/13/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for determining elapsed sensor life | ||
Patent #
US 9,949,678 B2
Filed 02/16/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 9,962,091 B2
Filed 01/06/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte signal processing device and methods | ||
Patent #
US 9,968,302 B2
Filed 04/04/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems | ||
Patent #
US 9,968,306 B2
Filed 10/21/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods | ||
Patent #
US 9,980,669 B2
Filed 11/07/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing data communication in continuous glucose monitoring and management system | ||
Patent #
US 10,039,881 B2
Filed 07/07/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Assist device and system | ||
Patent #
US 10,051,410 B2
Filed 09/19/2014
|
Current Assignee
UnaliWear Inc.
|
Original Assignee
UnaliWear Inc.
|
Analyte sensor | ||
Patent #
US 10,052,055 B2
Filed 11/05/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor fault detection using analyte sensor data pattern comparison | ||
Patent #
US 10,076,285 B2
Filed 03/13/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems, devices and methods for managing glucose levels | ||
Patent #
US 10,078,380 B2
Filed 04/07/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and device for providing offset model based calibration for analyte sensor | ||
Patent #
US 10,089,446 B2
Filed 09/03/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration of analyte measurement system | ||
Patent #
US 10,092,229 B2
Filed 06/29/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and apparatus for detecting false hypoglycemic conditions | ||
Patent #
US 10,117,606 B2
Filed 06/03/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods | ||
Patent #
US 10,178,954 B2
Filed 05/09/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensitivity calibration of in vivo sensors used to measure analyte concentration | ||
Patent #
US 10,188,334 B2
Filed 10/20/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Closed loop control and signal attenuation detection | ||
Patent #
US 10,188,794 B2
Filed 06/16/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Method and system for providing analyte monitoring | ||
Patent #
US 10,194,868 B2
Filed 11/10/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Accuracy of continuous glucose sensors | ||
Patent #
US 10,194,850 B2
Filed 07/14/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Arm mountable portable patient monitor | ||
Patent #
US 10,213,108 B2
Filed 03/03/2017
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Physiological measurement device | ||
Patent #
US 10,219,706 B2
Filed 10/11/2018
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Physiological measurement device | ||
Patent #
US 10,335,033 B2
Filed 11/21/2018
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Method and apparatus for providing notification function in analyte monitoring systems | ||
Patent #
US 10,349,874 B2
Filed 08/31/2017
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring system and methods for managing power and noise | ||
Patent #
US 10,429,250 B2
Filed 03/26/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Noise rejection methods and apparatus for sparsely sampled analyte sensor data | ||
Patent #
US 10,433,773 B1
Filed 03/13/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for sensing electrical activity in tissue | ||
Patent #
US 10,506,941 B2
Filed 05/17/2016
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,555,695 B2
Filed 07/02/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,561,354 B2
Filed 07/02/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods providing EN mass collection and centralized processing of physiological responses from viewers | ||
Patent #
US 10,580,018 B2
Filed 10/21/2016
|
Current Assignee
Nielsen Company US LLC
|
Original Assignee
The Nielsen Company LLC
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,610,141 B2
Filed 09/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,624,568 B2
Filed 08/13/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Wireless, disposable, extended use pulse oximeter apparatus and methods | ||
Patent #
US 10,646,144 B2
Filed 12/07/2016
|
Current Assignee
True Wearables Inc.
|
Original Assignee
Marcelo Malini Lamego, Tatiana Buticosky Lamego
|
Analyte monitoring system and methods | ||
Patent #
US 10,653,317 B2
Filed 01/10/2019
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Single use medical device apparatus and methods | ||
Patent #
US 10,659,963 B1
Filed 02/12/2019
|
Current Assignee
True Wearables Inc.
|
Original Assignee
True Wearables Inc.
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,682,084 B2
Filed 05/07/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Insulin delivery apparatuses capable of bluetooth data transmission | ||
Patent #
US 10,685,749 B2
Filed 12/28/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Assist device and system | ||
Patent #
US 10,687,193 B2
Filed 07/30/2018
|
Current Assignee
UnaliWear Inc.
|
Original Assignee
UnaliWear Inc.
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,722,162 B2
Filed 09/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Continuous glucose monitoring system and methods of use | ||
Patent #
US 10,750,952 B2
Filed 03/26/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods to gather and analyze electroencephalographic data | ||
Patent #
US 10,779,745 B2
Filed 01/25/2018
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Systems and methods for disease control and management | ||
Patent #
US 10,818,389 B2
Filed 11/12/2018
|
Current Assignee
WellDoc Inc
|
Original Assignee
WellDoc Inc
|
Advanced analyte sensor calibration and error detection | ||
Patent #
US 10,835,162 B2
Filed 09/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods to gather and analyze electroencephalographic data | ||
Patent #
US 10,842,403 B2
Filed 02/16/2016
|
Current Assignee
The Nielsen Company LLC
|
Original Assignee
The Nielsen Company LLC
|
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data | ||
Patent #
US 10,842,420 B2
Filed 03/02/2018
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Adaptive analytical behavioral and health assistant system and related method of use | ||
Patent #
US 10,846,607 B2
Filed 04/21/2020
|
Current Assignee
WellDoc Inc
|
Original Assignee
WellDoc Inc
|
Systems and methods for disease control and management | ||
Patent #
US 10,860,943 B2
Filed 04/14/2020
|
Current Assignee
WellDoc Inc
|
Original Assignee
WellDoc Inc
|
Physiological measurement communications adapter | ||
Patent #
US 10,869,602 B2
Filed 01/23/2018
|
Current Assignee
Masimo Corporation
|
Original Assignee
Masimo Corporation
|
Systems and methods for disease control and management | ||
Patent #
US 10,872,686 B2
Filed 04/21/2020
|
Current Assignee
WellDoc Inc
|
Original Assignee
WellDoc Inc
|
Multi-rate analyte sensor data collection with sample rate configurable signal processing | ||
Patent #
US 10,874,336 B2
Filed 10/12/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients | ||
Patent #
US 6,024,699 A
Filed 03/13/1998
|
Current Assignee
Roche Diabetes Care Inc.
|
Original Assignee
HealthWare Corporation
|
Networked system for interactive communication and remote monitoring of individuals | ||
Patent #
US 5,997,476 A
Filed 10/07/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Physiological monitor and associated computation, display and communication unit | ||
Patent #
US 6,790,178 B1
Filed 09/25/2000
|
Current Assignee
MICROLIFE MEDICAL HOME SOLUTIONS INC.
|
Original Assignee
HealtheTech Inc.
|
Personal medical monitoring unit and system | ||
Patent #
US 6,579,231 B1
Filed 03/27/1998
|
Current Assignee
Apple Inc.
|
Original Assignee
MCI Communications Corporation
|
Networked system for interactive communication and remote monitoring of individuals | ||
Patent #
US 6,368,273 B1
Filed 04/28/1999
|
Current Assignee
Robert Bosch LLC
|
Original Assignee
Health Hero Network Incorporated
|
Wireless internet bio-telemetry monitoring system | ||
Patent #
US 6,443,890 B1
Filed 03/01/2000
|
Current Assignee
PhDx Systems Inc.
|
Original Assignee
I-Medik Inc.
|
Remote health monitoring and maintenance system | ||
Patent #
US 6,168,563 B1
Filed 03/17/1999
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Health monitoring system | ||
Patent #
US 6,282,441 B1
Filed 11/23/1999
|
Current Assignee
Brigham and Womens Hospital Incorporated
|
Original Assignee
Brigham and Womens Hospital Incorporated
|
Multi-user remote health monitoring system | ||
Patent #
US 6,101,478 A
Filed 11/21/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Health monitoring system | ||
Patent #
US 6,095,985 A
Filed 12/30/1997
|
Current Assignee
Brigham and Womens Hospital Incorporated
|
Original Assignee
Brigham and Womens Hospital Incorporated
|
Monitoring system for remotely querying individuals | ||
Patent #
US 5,897,493 A
Filed 04/30/1997
|
Current Assignee
Health Hero Network Incorporated
|
Original Assignee
Health Hero Network Incorporated
|
Health monitoring system | ||
Patent #
US 5,778,882 A
Filed 02/24/1995
|
Current Assignee
Brigham and Womens Hospital Incorporated
|
Original Assignee
Brigham and Womens Hospital Incorporated
|
32 Claims
-
1. A system for monitoring a patient, comprising:
-
a vital-sign monitor comprising sensors for measuring from the patient at least one of the following vital-sign data;
O2 saturation, blood pressure, heart rate, electro-cardiogram, respiratory rate, temperature and blood glucose level;
a global positioning system for determining location-based data;
a wireless transmitter configured to receive the vital-sign and location-based data and wirelessly transmit these data through a wireless network;
a gateway software piece that receives and processes the vital-sign and location-based data from the wireless network;
a database software piece that communicates with the gateway software piece to receive the vital-sign and location-based data and stores them in a computer memory; and
an Internet-based user interface that displays the vital sign and location-based data. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
-
-
28. A system for monitoring a patient, comprising:
-
a vital-sign monitor comprising;
sensors for measuring from the patient at least one of the following vital-sign data;
O2 saturation, blood pressure, heart rate, electro-cardiogram, respiratory rate, temperature and blood glucose level;
a global positioning system that generates location-based data; and
a wireless component that transmits the vital-sign and location-based data and receives component code;
a wireless transmitter configured to receive the vital-sign and location-based data and wirelessly transmit these data through a wireless network;
a gateway software piece that receives and processes the vital-sign and location-based data from the wireless network;
a database software piece that communicates with the gateway software piece to receive the vital-sign and location-based data and stores them in a computer memory; and
an Internet-based user interface that displays the vital sign and location-based data and comprises a first interface that displays vital-sign and location-based data for a single patient and a second interface that displays vital sign and location-based data for a plurality of patients.
-
-
29. A system for monitoring a patient, comprising:
a vital-sign monitor comprising a sensor for measuring data characterizing O2 saturation from the patient;
a global positioning system for determining location-based data;
a wireless transmitter configured to receive the data and wirelessly transmit these data through a wireless network;
a gateway software piece that receives and processes the data from the wireless network;
a database software piece that communicates with the gateway software piece to receive the data and store them in a computer memory; and
an Internet-based user interface that displays the data and comprises a first interface that displays vital-sign and location-based data for a single patient and a second interface that displays vital-sign and location-based data for a plurality of patients.
-
30. A system for monitoring a patient, comprising:
-
a vital-sign monitor integrated into a finger-worn unit comprising a sensor that measures data characterizing O2 saturation from the patient;
a global positioning system for determining location-based data; and
a processor, in wired or unwired electrical contact with the vital-sign monitor and the global positioning system, that receives and processes the O2 saturation and location-based data.
-
-
31. A system for monitoring a patient, comprising:
-
a blood-pressure monitor that measures O2 saturation data from the patient;
a processor, in wired or unwired electrical contact with the monitor, that receives and processes the O2 saturation data to determine blood pressure; and
a wireless transmitter configured to receive blood pressure data and transmit this information through a wireless network.
-
-
32. A system for monitoring a patient, comprising:
-
a blood-pressure monitor integrated into a finger or wrist-worn unit comprising a sensor that measures data characterizing O2 saturation and blood pressure from the patient;
a processor, in wired or unwired electrical contact with the monitor, that receives and processes the O2 saturation and blood pressure data; and
a wireless transmitter configured to receive the O2 saturation and blood pressure data from the processor and transmit these data through a wireless network.
-
1 Specification
This application claims the benefit of U.S. Provisional Application No. 60/438,442, filed Jan. 7, 2003.
The present invention features a wireless, internet-based system for diagnosing a patient.
Medical professionals use a variety of medical devices to measure a patient'"'"'s vital signs during a routine checkup. Such devices can measure, for example, blood pressure, blood oxygen saturation (called O2 saturation), electrocardiograms, heart rate, respiratory rate, and blood glucose level. A sphygmomanometer measures blood pressure with an inflatable cuff and sensing electronics that determine the patient'"'"'s systolic and diastolic blood pressure. Another medical device, called a pulse oximeter, clips to the patient'"'"'s finger and measures the percentage of haemoglobin that is saturated with oxygen. To make this measurement, the pulse oximeter includes separate light sources (e.g. diode lasers or light-emitting diodes) that emit radiation at two different wavelengths (typically 650 nm and 805 nm). Haemoglobin in the blood partly absorbs the light to a degree that depends on whether it is saturated or desaturated with oxygen. A calculator in the oximeter calculates the absorption at the two wavelengths and computes the proportion of haemoglobin that is oxygenated. The data are dependant on a pulsatile flow of blood and are typically plotted as a waveform that the calculator additionally analyzes to determine the patient'"'"'s heart rate.
An electrocardiography measurement device measures a patient'"'"'s electrocardiogram (ECG) with at least three conductive electrodes that attach to the patient. The electrodes detect time-dependent electrical impulses generated by the patient'"'"'s beating heart. The measurement device also includes software that analyzes the impulses to determine a time-dependent waveform from which the patient'"'"'s heart rate and cardiac response are calculated. The same electrodes used to measure an ECG can also include transducers or accelerometers that detect a patient'"'"'s respiratory (i.e. breathing) rate.
Diabetic patients typically monitor their blood glucose level using a simple device called a glucometer. For these measurements, the patient draws a small sample of blood (by pricking a finger, for example) and applies this to a test strip. The patient then inserts the test strip into the glucometer, which includes an electrical system to determine the electrical properties of the blood. Software in the glucometer uses these properties to determine the patient'"'"'s glucose level.
In typical applications, data indicating blood pressure, O2 saturation, ECG, heart rate, and respiratory rate are measured during a patient'"'"'s appointment with a medical professional, such as a doctor, nurse, or certified diabetic educator. Once measured, the medical professional manually records these data in either a written or electronic file. Appointments typically take place a few times each year. And in some cases patients experience ‘white coat syndrome’ where anxiety during the appointment affects the vital signs that are measured. For example, white coat syndrome can elevate a patient'"'"'s heart rate and blood pressure; this, in turn, can lead to an inaccurate diagnoses.
A diabetic patient will typically use a glucometer to measure their blood glucose levels several times each day, typically before and after meals. The patient may record the data in a logbook, which is then reviewed during at home or during a medical appointment. Some glucometers additionally include both electronic memory and a serial interface. In this case a personal computer equipped with the appropriate software and serial cable can download data from the glucometer and store it electronically in a file. The software may also include graphical capabilities that can, for example, plot data so that the patient can make a relatively sophisticated analysis of their blood glucose level.
Some medical devices for measuring the above-mentioned vital signs include systems for transmitting data from a remote site, such as the patient'"'"'s home, to a central database. These systems can include a conventional computer modem that transmits data through a telephone line to the database. Or alternatively they can include a wireless transmitter, such as a cellular telephone or a radio modem, which wirelessly transmits the data through a wireless network.
In general, in one aspect, the invention features a wireless, internet-based medical device for remotely monitoring a patient. Specifically, it measures data characterizing a patient'"'"'s vital signs, wirelessly transmits these data through a wireless network to an internet-accessible software piece, analyzes the data, and then avails the analyzed data over a web site hosted on the internet. A medical professional, such as a registered nurse working in a call center, can view and analyze these data in real-time to accurately diagnose the patient. In this way a thorough medical ‘appointment’ can be conducted over the telephone or Internet while the patient remains at home. A single medical professional can monitor hundreds of patients, each in separate remote site, using the Internet.
In general, in another aspect, the invention features a system for monitoring a patient'"'"'s vital signs that includes a vital-sign monitor. The monitor includes sensors for measuring from the patient at least one of the following vital-sign data: O2 saturation, blood pressure, ECG, respiratory rate, and blood glucose level. The system also includes a wireless transmitter, in electrical contact with the vital-sign monitor, that receives the vital-sign data and wirelessly transmits these data through a conventional wireless network. A gateway software piece then receives and processes the vital-sign data from the wireless network and stores these data in a database associated with a database software piece. The system also includes separate Internet-based user interfaces that display the vital sign data for: 1) individual users (e.g., a ‘patient interface’); and 2) groups of users (e.g., a ‘care-provider interface’) associated with a care-provider.
In one embodiment, the Internet-based user interface features a login functionality that analyzes input information (e.g., a login and password) and in response renders either the first or second interface.
The care-provider interface typically includes a numerical table that displays the vital-sign data associated with the plurality of patients (e.g., users). This interface can also display an ‘alert’ message associated with a user. For example, alert messages can be text messages with associated graphics that indicate a patient'"'"'s status. To generate such alert messages, the system can include an application software piece that processes vital-sign data. To generate the alert message, the software piece can be an algorithm that compares the vital-sign data to a pre-determined level. Or the software piece can process multiple vital-sign data, or the patient'"'"'s gender or age, to generate the alert message.
In other embodiments, the system further includes a first software component that transmits an electronic file, and the vital-sign monitor includes a second software component that receives the electronic file. In this case the Internet-based user interface includes a web page that sends an email, electronic message, or database-generated report, such as pre-determined file stored in the database, to a patient. The messages can be automatically sent following analysis of the vital-sign data.
In some embodiments, the first software component is configured to transmit data formatted in an XML-based format (e.g. an XML document). The XML-based format can be compatible with a second Internet-based software system. In particular, the XML-based format can integrate with a Web Services software system so that information can be sent from one web-based application to another. In other embodiments, the vital-sign monitor further includes a display that displays an email or electronic message received from the Internet. The second software component can be configured to receive and process wirelessly transmitted computer code. For example, the computer code can update the vital-sign monitor'"'"'s existing computer code. Or it can function to load a schema into the monitor'"'"'s memory, or modify its transmission properties (e.g., the frequency at which it transmits data, or the type of data that are transmitted).
In general, in still another aspect, the invention features a system for monitoring a patient that includes a vital-sign monitor integrated into a unit that is head-worn, wrist-worn or finger-worn. The monitor can include both wrist-worn and finger-worn components. The vital-sign monitor includes a sensor that measures data characterizing O2 saturation from the patient. Typically for the head-worn unit the data are measured from a region on the patient'"'"'s head. The system also includes a global positioning system that determines location-based data. A processor, in wired or unwired electrical contact with the vital-sign monitor and the global positioning system, receives and processes the O2 saturation and location-based data to determine the patient'"'"'s vital signs and location. The head-worn unit can also include a display or an earpiece using a text-to-speech controller to display or describe the vital signs. Such a device, for example, could be used during exercise (e.g., jogging).
In an embodiment, the head-worn unit is a pair of eyeglasses or sunglasses that features an optical sensor measuring O2 saturation from the patient'"'"'s earlobe. The display is integrated into a transparent portion of the eyeglasses, or the earpiece can be integrated into the frames near the patient'"'"'s ear. In either case, the patient is made aware of their O2 saturation and location-based data, and derivatives thereof, during exercise. The finger-worn unit can take the form of a finger ring.
In general, in still yet another aspect, the invention features a system for monitoring a patient that includes a blood-pressure monitor that measures O2 saturation data from the patient. A processor, in wired or unwired electrical contact with the monitor, receives and processes the O2 saturation data to determine blood pressure. A wireless transmitter receives the blood pressure data and transmits this information through a wireless network.
In general, in another aspect, the invention features a patient monitoring system that includes a blood-pressure monitor integrated into a finger or wrist-worn unit comprising a sensor that measures data characterizing O2 saturation and blood pressure from the patient. A processor, in wired or unwired electrical contact with the monitor, receives and processes the O2 saturation and blood pressure data. And a wireless transmitter receives the O2 saturation and blood pressure data from the processor and transmits these data through a wireless network.
In the above-described systems, the term ‘wireless network’ refers to a standard wireless communication network (e.g., CDMA networks provided by companies such as Sprint and Verizon; GSM/GPRS networks provided by ATT and Cingular; or wireless data networks such as the Mobitex or DataTac networks). These networks connect a wireless transmitter or a silicon-based chipset to the Internet-based software piece. Also in the above-described methods, the ‘measuring’ and ‘transmitting’ steps can be performed at any time and with any frequency, depending on the diagnoses being performed. The wireless network may also short-range wireless transmitters and receivers. These devices, for example, may use wireless protocols such as any version of 802.11 (e.g., 802.11b), Bluetooth™, or a short-range radio protocol.
The term ‘web page’ refers to a standard, single graphical user interface or ‘page’ that is hosted on the Internet or worldwide web. Web pages typically include: 1) a ‘graphical’ component for displaying a user interface (typically written in a computer language called ‘HTML’ or hypertext mark-up language); an ‘application’ component that produces functional applications, e.g. sorting and customer registration, for the graphical functions on the page (typically written in, e.g., C++ or java); and a database component that accesses a relational database (typically written in a database-specific language, e.g. SQL*Plus for Oracle databases). A ‘web site’ typically includes multiple web pages, many of which are ‘linked’ together, that are accessed through a series of ‘mouse clicks’.
Different embodiments of the invention include one or more of the following advantages. They allow one or more medical professionals to remotely analyze a large group of patients accurately and in real-time. Patients can measure their vital signs and subsequently have these data monitored by a medical professional located thousands of miles away. Data measured with high frequency (e.g., several times each day) provide a relatively comprehensive data set compared to that measured during medical appointments separated by several weeks or even months. This allows both the patient and medical professional to observe trends in the data, such as a gradual increase or decrease in a particular vital sign, which may indicate a medical condition. And they minimize effects of white coat syndrome since the patient can make measurements at home or work.
Diabetic patients can use at least some of the embodiments to wirelessly transmit their blood glucose level after each measurement, making it unnecessary to record these data in a logbook. Patients with Internet access can view data analyzed with a variety of algorithms. Similarly, parents can remotely view data measured by their children. During medical appointments professionals can view the data and adjust a patient'"'"'s exercise and diet to better control their diabetes. A call center staffed by medical professionals can use the invention to constantly monitor patients, such as patients with severe cardiac conditions, and quickly respond in the case of emergency.
Ultimately various embodiments of the wireless, internet-based medical-diagnostic system described herein provide an in-depth, cost-effective mechanism to evaluate a patient'"'"'s medical condition. Certain medical conditions can be controlled, and in some cases predicted, before they actually occur. Moreover, data from the patient can be collected and analyzed, often in a continuous manner, while the patient participates in their normal, day-to-day activities. This provides a relatively comprehensive diagnosis that is not possible using a conventional medical-diagnostic system.
An internet-based software system for medical diagnoses can also be easily updated and made available to a large group of users simply by updating software on the web site. In contrast, a comparable updating process for a series of in-hospital medical devices can only be accomplished by updating the software on each individual device. This, of course, is time-consuming, inefficient, and expensive, and introduces the possibility that many devices within a particular product line will not have the very latest software.
The device used to access and transmit the patient'"'"'s data can be small, portable, and low-cost. Measurements are made in a matter of minutes and transmitted with a latency of a few seconds. A single device can also be used to measure and transmit data from multiple patients, provided it includes software and hardware that allows each patient to enter an identifying code that is, in turn, associated with their respective vital-sign data.
The resulting data, of course, have many uses for patients, medical professional, insurance companies, pharmaceutical agencies conducting clinical trials, and organizations for home-health monitoring.
These and other advantages of various embodiments of the invention are described in the following detailed disclosure and in the claims.
The features and advantages of embodiments of the present invention can be understood by reference to the following detailed description taken with the drawings, in which:
The vital-sign monitor 40 includes systems that measure, e.g., blood pressure, O2 saturation, ECGs, heart rate, respiratory rate, and blood glucose level. After these data are measured, software in the monitor 40 formats them into a data packet. The monitor radiates the packet to a base station 11 included in the wireless network 4. A host computer system 5 running a gateway software piece connects to the wireless network 4 and receives data packet from multiple vital-sign monitors. The host computer system 5, for example, may include multiple computers, software pieces, and other signal-processing and switching equipment, such as routers and digital signal processors. The wireless network 4 typically transfers data to the host computer system 5 using a TCP/IP-based connection, or with a dedicated digital leased line (e.g., a frame-relay circuit or a digital line running an X.25 protocol). The host computer system 5 also hosts the web site 6 using conventional computer hardware (e.g. computer servers for both a database and the web site) and software (e.g., web server and database software).
The patient 32 accesses a patient interface 14 hosted on the web site 6 through the Internet 7 from a secondary computer system 8. The patient interface 14 displays vital-sign data measured from a single patient. A call center 12, typically staffed with medical professionals such as doctors, nurses, or nurse practioners, accesses a care-provider interface 13 hosted on the website 6. The care-provider interface 13 displays vital-sign data from multiple patients. Both the patient and care-provider interfaces are described in more detail with references to
The vital-sign monitor 40 additionally includes a GPS system that receives GPS signals from a conventional GPS satellite system 24 and processes these signals to determine a location (more specifically the latitude, longitude, and altitude) of the monitor and, presumably, the patient. This location, for example, could be used to locate a patient during an emergency for purposes of dispatching an ambulance.
The appliance transmits separate data packets through the wireless network 11 that feature a ‘payload’ containing either the vital-sign data or the GPS-determined location. Typically these data are sent in separate packets, although they could be bundled into a single packet. The data packets additionally contain information of the packets'"'"' status, an address describing their destination, and an address describing their origin. These data packets are transmitted over conventional wireless network, such as a CDMA, GSM/GPSRS, Mobitex, or DataTac network. The specific network is associated with the wireless transmitter used by the monitor to transmit the data packet.
The microprocessor module 46 collects GPS location-based data from a GPS receiver 48 through a second serial interface 47b, also communicating with an RS-232 or other serial protocol. The GPS receiver 48 generates the location-based data by collecting GPS signals from orbiting GPS satellites using a GPS antenna 52. Both the GPS receiver 48 and the sensors for measuring vital signs 50 may continually and automatically send data across the respective serial ports 47b, 47c at a well-defined frequency (e.g., every second). Or they may only send data in response to a command sent by the microprocessor module 46.
Once the microprocessor module 46 collects vital-sign and location-based data, these data are formatted into separate packets and transmitting through a third serial interface 47a to a radio modem 44. The radio modem 44 functions as a wireless transmitter that transmits data packets through an antenna 42 and over a wireless network. As described above, the wireless network chosen to transmit the data packets will dictate the type of wireless transmitter used in the monitor 40.
The microprocessor module 46 runs software and a data-collection ‘schema’ loaded into memory 49, such as a random-access memory. The schema is essentially a ‘map’ that describes: i) the type of data collected from the sensors for monitoring vital signs 50 and the GPS receiver 48; ii) the frequency that these data are collected; and iii) the frequency that these data are transmitted. A schema specific to a given set of sensors is typically loaded onto the memory 49 before the monitor is distributed to a patient. During operation, the vital-sign monitor collects vital-sign and location-based data defined by the schema, and transmits these data in packets as described above. The network transfers the data packet to the host computer system. There, the host computer system analyzes the data packet using a ‘map’ that corresponds to the schema to generate a data set. Every schema has a corresponding map. The map includes, for example, a list of the collected data, and an acronym and unit for each datum. The data set, acronym, and units are then displayed on the web site and are viewed by any ‘registered’ user (i.e., a patient or call center employee with a username and corresponding password) with Internet connectivity.
According to the method described above, a call-center operator monitors these data by accessing the web page 100 through the Internet. After analyzing the data, the operator can use the web page 100 to access other data corresponding to the patient, such as their current medication using button 98, or their medical records using button 94. The operator can also search for a particular patient by entering their last name in a search field 90 and then clicking a ‘search’ button 91. Or the operator can register a new patient by clicking on a ‘Register Patient’ button 98 included in the left-hand navigation bar 80.
The call-center operator diagnoses the patient using the vital-sign data in a manner similar to protocols used during a conventional medical appointment. By using the above-described method, however, the operator can efficiently monitor hundreds of patients, each in a remote location, through the Internet. For example, following analysis, the operator may send the patient to a hospital, or may recommend a therapy to the patient using a telephone, email, or Internet-based instant message. Or if the patient'"'"'s data looks normal the operator may deem the patient healthy and issue a clean bill of health.
Both the care-provider and patient interfaces may additionally include comprehensive displays of the patient'"'"'s time-dependent vital-sign data.
For example, the web page 149 shown in
The graph 154 shows a simple plot of the patient'"'"'s glucose level vs. a time/date stamp corresponding to a particular measurement. These time-dependent data are then compared to the same suggested values (in this case 105 mg/dL) of glucose listed in the table 152. The graph 154 shows both the patient and call-center operator trends in the glucose level. These trends, for example, may be used to adjust the patient'"'"'s diet, exercise level, or insulin dosage.
Using the above-described system, following analysis of the vital-sign data a call-center operator may contact a patient to describe a potential medical problem. The operator may use a conventional telephone, or an Internet-based contact method such as an email or instant message.
Other embodiments are also within the scope of the invention. In particular, the web pages used to display the data can take many different forms, as can the manner in which the data are displayed. Web pages are typically written in a computer language such as ‘HTML’ (hypertext mark-up language), and may also contain computer code written in languages such as java and javascript for performing certain functions (e.g., sorting of names). The web pages are also associated with database software (provided by companies such as Oracle and Microsoft) that is used to store and access data. Equivalent versions of these computer languages and software can also be used. In general, the graphical content and functionality of the web pages may vary substantially from what is shown in the above-described figures. In addition, web pages may also be formatted using standard wireless access protocols (WAP) so that they can be accessed using wireless devices such as cellular telephones, personal digital assistants (PDAs), and related devices.
Different web pages may be designed and accessed depending on the end-user. As described above, individual users have access to web pages that only their vital-sign data (i.e., the patient interface), while organizations that support a large number of patients (e.g. hospitals) have access to web pages that contain data from a group of patients (i.e., the care-provider interface). Other interfaces can also be used with the web site, such as interfaces used for: insurance companies, members of a particular company, clinical trials for pharmaceutical companies, and e-commerce purposes. Vital-sign data displayed on these web pages, for example, can be sorted and analyzed depending on the patient'"'"'s medical history, age, sex, medical condition, and geographic location.
The web pages also support a wide range of algorithms that can be used to analyze data once it is extracted from the data packets. For example, the above-mentioned instant message or email can be sent out as an ‘alert’ in response to vitals signs indicating a medical condition that requires immediate attention. Alternatively, the message could be sent out when a data parameter (e.g. temperature) exceeded a predetermined value. In some cases, multiple parameters (e.g., O2 saturation, ECG waveform) can be analyzed simultaneously to generate an alert message. In general, an alert message can be sent out after analyzing one or more data parameters using any type of algorithm. These algorithms range from the relatively simple (e.g., comparing blood pressure to a recommended value) to the complex (e.g., predictive medical diagnoses using ‘data mining’ techniques). In some cases data may be ‘fit’ using algorithms such as a linear or non-linear least-squares fitting algorithm. In general, any algorithm that processes data collected with the above-described method is within the scope of the invention.
In other embodiments, additional hardware can be added to the medical device to modify its performance. For example, the radio modem used to transmit the data may employ a terrestrial GPS system, such as that available on modems designed by Qualcomm, Inc. In general, the wireless transmitter and general system described above can be used to transmit data generated with any medical device, including devices that measure or characterize cholesterol, coumadin levels, clotting factors, proteins or antibodies, illegal substances, or levels pharmaceutical compounds.
In certain embodiments, the wireless transmitter transmits blood pressure, heart rate, and O2 saturation information determined from a hand or finger-worn monitor. The blood pressure information may be determined from a finger-worn monitor that measures O2 saturation. In other embodiments, the monitor can be used to characterize a wide range of maladies, such as diabetes, congestive heart failure, sleep apnea and other sleep disorders, asthma, heart attack and other cardiac conditions, stroke, Alzheimer'"'"'s disease, and hypertension.
In still other embodiments, the vital-sign monitor or components thereof and GPS electronics are integrated into other devices to perform the above-described measurements. For example, in one embodiment, the sensor for the pulse oximeter makes a measurement from the patient'"'"'s earlobe and is integrated into a head-worn unit, e.g. a pair of eyeglasses or sunglasses. In this case, electronics that analyze the signals generated from the sensor can also be integrated into the head-worn unit (e.g., into the frames of the eyeglasses) or into a belt-worn module that, in turn, is attached to the head-worn unit using a wired or unwired (e.g., short-range wireless) connection. The belt-worn unit includes a controller and serial port that, respectively, analyze the data and download the data to an external computer. A display (e.g., a ‘head'"'"'s up’ or holographic display) for displaying the vital-sign measurements can be integrated into the head-worn unit, e.g. into the transparent glass portion of the eyeglasses. In this way, for example, a patient can monitor his real-time vital signs during exercise or everyday activities. Alternatively, a text-to-speech controller can be used to describe the data in an audio manner to the patient.
The head-worn embodiment of the vital-sign monitor can also include memory that stores the measured vital signs and a GPS-determined location. This way, the location and vital-sign data can be downloaded to a computer through the serial port and viewed by the patient. This allows, for example, a patient to monitor his vital signs as a function of location or time. Such a device would be particularly useful for training purposes for athletes, e.g. marathon runners.
In a related embodiment, the sensor for the pulse oximeter takes the form of a finger ring or an adhesive patch and is connected to the belt-worn module as described above. The connection can be a wired or unwired connection.
Still other embodiments are within the scope of the following claims.